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Purpose: Regionalization of care for ST-segment elevation myocardial
infarction (STEMI) has been advocated, although its effect on processes of
care – compared with secular evolution – remains uncertain. The aim of this
study was to evaluate the impact of a regional system of care on reperfusion
strategies for STEMI patients relative to control hospitals.
Methods: We analysed the original data from two nationwide, prospective
cohort studies, with the same methods. The fisrt was conducted in November
2000 (FAST MI 2010) and the second in November 2005 (FAST MI 2005).
A total of 160 French hospitals participated in both studies. Seven hospitals
(2 with percutaneous coronary intervention facilities and 5 without) were
involved in a regional system of care implemented in the Northern Alps in
2002 (RESURCOR); 153 control hospitals were located in other French areas
with no corresponding regional system of care. From 2002 to 2005,
RESURCOR promoted prehospital fibrinolysis followed by routine/rescue
coronary angiography. We compared change in rate of prehospital fibrinolysis
and routine/rescue coronary angiography after fibrinolysis between 2000 and
2005 in the RESURCOR region versus the control hospitals.
Results: A total of 102 STEMI patients were enrolled in the Northern Alps
hospitals and 2377 in the control hospitals. In the RESURCOR area we
observed a larger absolute increase in the use of prehospital fibrinolysis (18%
vs 63%, P<0.01, respectively, in 2000 and 2005) compared with the control
hospitals (14% vs 31%, P<0.01, respectively, in 2000 and 2005). In the
RESURCOR area we observed a larger absolute increase in the use of routine/
rescue coronary angiography after fibrinolysis (9% vs 44%, P<0.01, respec-
tively, in 2000 and 2005) when compared with control hospitals (7% vs 22%,
P<0.01, respectively, in 2000 and 2005).
Conclusion: Regionalization of care for STEMI patients may impact on
reperfusion strategy in STEMI.
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Purpose: To determine the actual management of ST-elevation myocardial
infarction (STEMI) in octogenarian patients and more.
Methods: We analyzed data collected in “ORBI”, a 6 years prospective
registry of STEMI patients admitted within 24 h of symptoms onset to an
interventional cardiology centre of Brittany (France). Main data about man-
agement and intra hospital outcome were compared between patients older
(Group 1) and younger (Group 2) than 80.
Results: 550 of the 5000 patients (11%, mean age 84.6 ±3) constituted
group 1, with a larger female prevalence (51 vs 20% in group 2, p<0.0001).
Group 1 had a much longer median delay between onset of symptom and call
for medical assistance (65 vs 45 min.), and between admission and reperfusion
(53 vs 45 min.). Table 1 presents data about the management in the 2 groups,
both in the acute phase and at discharge. Last, intra hospital mortality is much
higher in group 1 (16.5 vs 4.1%, p<0.0001).
Conclusions: Octogenarian patients and more represent a large part of
patient treated for STEMI, with significant differences in their presentation
and management, and a high mortality.
Table 1 – *Percentages are calculated only in patients undergoing coronary 
angiography
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Background: Recent clinical studies suggest that low molecular weight
heparin (LMWH) could be an effective and safe alternative to unfractionated
heparin (UFH) for patients with acute myocardial infarction (AMI).
Aims: To assess the impact of the choice of anticoagulant (LMWV vs.
UFH) on bleeding, the need for blood transfusion and three-year clinical out-
comes in patients with AMI from the FAST-MI registry.
Methods: FAST-MI is a nationwide registry carried out in France over a
1-month period in 2005, including consecutive patients with AMI admitted to
intensive care unit <48h from symptom onset in 223 participating centers.
Group 1
>80years old
n=550
Group 2
≤ 80 years old
=4450
Initial 
management
Fibrinolysis 38 (7%) 723 (16%) <0.0001
GP IIb/IIIa 
receptor 
inhibitors 
223 (40%) 2674 (60%) <0.0001
Coronary 
angiography
493 (89%) 4402 (99%) <0.0001
Radial access* 140 (28%) 1511 (34%) <0.0001
Primary 
angioplasty*
386 (78%) 3197 (72%) 0.4
Thrombo 
aspiration*
163 (33%) 1874 (42%) <0.0001
Intra hospital 
outcome
High degree 
AV block
40 (7%) 140 (3%) <0.0001
Atrial 
fibrillation
59 (10%) 161 (3.6%) <0.0001
Left ventricular 
ejection 
fraction (%)
47.2±12 50.6±10 <0.0001
Total length 
of stay (days)
8.2±5 6.8±4 <0.0001
Prescription 
at discharge
Aspirine 439 (95,6%) 4167 (97,7%) 0,007
Clopidogrel/
Prasugrel
413 (90,0%) 4086 (95,8%) <0,0001
β blockers 394 (85,8%) 3895 (91,3%) <0,0001
ACE inhibitor 290 (63,2%) 2853 (66,9%) 0,1
Statine 373 (81,3%) 4057 (95,1%) <0,0001
Cardiovascular 
rehabilitation
22 (5,3%) 1822 (46,6%) <0,0001
